Deposition of small particles in the developing lung

Becquemin, 1991, Particle deposition and resistance in the noses of adults and children, Eur Respir J, 4, 694, 10.1183/09031936.93.04060694 Hislop, 1972, Postnatal growth and function of the pre-acinar airways, Thorax, 27, 265, 10.1136/thx.27.3.265 Howarth, 2001, Why Particle Size Should Affect Clinical Response to Inhaled Therapy, J Aerosol Med, 14, S27, 10.1089/08942680150506312 Mallol, 1996, Aerosol deposition in infants with cystic fibrosis, Pediatr Pulmonol, 21, 276, 10.1002/(SICI)1099-0496(199605)21:5<276::AID-PPUL2>3.0.CO;2-L Fok, 1996, Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia, Pediatr Pulmonol, 21, 301, 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P Amirav, 2002, Beta Agonist Aerosol Distribution in RSV Bronchiolitis in Infants, J Nucl Med, 43, 487 Chua, 1994, The influence of age on aerosol deposition in children with cystic fibrosis, Eur Respir J, 7, 2185, 10.1183/09031936.94.07122185 Cockcroft, 1979, Nasal airway inspiratory resistance, Am Rev Respir Dis, 119, 921 Wildhaber, 1999, Inhalation therapy in asthma; Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children, J Pediatr, 135, 28, 10.1016/S0022-3476(99)70323-9 Tal, 1996, Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction, J Pediatr, 128, 479, 10.1016/S0022-3476(96)70357-8 Murakami, 1990, Measurement of bronchial hyperreactivity in infants and preschool children using a new method, Ann Allergy, 64, 383 Iles, 1999, Crying significantly reduces absorption of aerosolised drug in infants, Arch Dis Child, 81, 163, 10.1136/adc.81.2.163 Amirav, 2003, Nebulizer Hood Compared to Mask in Wheezy Infants: Aerosol Therapy Without Tears!, Arch Dis Child, 88, 719, 10.1136/adc.88.8.719 Schueepp, 2009, Aerosol delivery of nebulised budesonide in young children with asthma, Respir Med, 103, 1738, 10.1016/j.rmed.2009.04.029 Janssens, 2004, Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model, J Aerosol Med, 17, 51, 10.1089/089426804322994460 Amirav, 2001, Aerosol therapy with valved holding chambers in young children: importance of the facemask seal, Pediatrics, 108, 389, 10.1542/peds.108.2.389 Amirav, 2008, Review of optimal characteristics of face-masks for valved-holding chambers (VHCs), Pediatr Pulmonol, 43, 268, 10.1002/ppul.20767 Everard, 1992, Drug delivery from jet nebulisers, Arch Dis Child, 67, 586, 10.1136/adc.67.5.586 Sangwan, 2004, Facemasks and Facial Deposition of Aerosols, PediatrPulmonol, 37, 447 Marguet, 2001, Inhalation treatment: Errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children, Pediatr Allergy Immunol, 12, 224, 10.1034/j.1399-3038.2001.012004224.x Clark, 2007, The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols, J Aerosol Med, 20, 75, 10.1089/jam.2006.0557 Everard, 2000, Trying to deliver aerosols to upset children is a thankless task, Arch Dis Child, 82, 428, 10.1136/adc.82.5.428a Leach, 1999, Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans, J Allergy Clin Immunol, 104, S250, 10.1016/S0091-6749(99)70041-2 Janssens, 2003, Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model, Chest, 123, 2083, 10.1378/chest.123.6.2083 Schuepp, 2005, In vitro determination of the optimal particle size for nebulized aerosol delivery to infants, J Aerosol Med, 18, 225, 10.1089/jam.2005.18.225 Schüepp, 2004, A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children, Swiss Med Wkly, 134, 198 Köhler, 2008, Lung deposition after inhalation with various nebulisers in preterm infants, Arch Dis Child Fetal Neonatal Ed, 93, F275, 10.1136/adc.2007.121285 Geller, 1998, Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group, Pediatr Pulmonol, 25, 83, 10.1002/(SICI)1099-0496(199802)25:2<83::AID-PPUL2>3.0.CO;2-O Agertoft, 2003, Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children, Pediatr Pulmonol, 35, 192, 10.1002/ppul.10238 Devadason, 2003, Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children, Eur Respir J, 21, 1007, 10.1183/09031936.03.00087803 Roller, 2007, Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children, Eur Respir J, 29 Ducharme, 2009, Preemptive use of high-dose fluticasone for virus-induced wheezing in young children, N Engl J Med, 360, 339, 10.1056/NEJMoa0808907 Pedersen, 2002, Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children, Pediatrics, 109, e92, 10.1542/peds.109.6.e92 Skoner, 2008, Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma, Pediatrics, 121, e1, 10.1542/peds.2006-2206 Lasserson, 2006, Fluticasone versusHFA-beclomethasone dipropionate for chronic asthma in adults and children, Cochrane Database Syst Rev, 10.1002/14651858.CD005309.pub3